Zimmer Biomet Holdings, Inc. Share Price

Equities

ZBH

US98956P1021

Medical Equipment, Supplies & Distribution

Market Closed - Nyse 21:00:02 26/04/2024 BST 5-day change 1st Jan Change
119.4 USD -0.33% Intraday chart for Zimmer Biomet Holdings, Inc. -0.07% -1.93%
Sales 2024 * 7.74B 620B Sales 2025 * 8.1B 649B Capitalization 24.52B 1,963B
Net income 2024 * 1.05B 84.3B Net income 2025 * 1.2B 96.38B EV / Sales 2024 * 3.67 x
Net Debt 2024 * 3.93B 314B Net Debt 2025 * 2.6B 208B EV / Sales 2025 * 3.35 x
P/E ratio 2024 *
22.8 x
P/E ratio 2025 *
20.3 x
Employees 18,000
Yield 2024 *
0.88%
Yield 2025 *
0.87%
Free-Float 64.92%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.33%
1 week-0.07%
Current month-9.57%
1 month-10.00%
3 months-1.92%
6 months+15.66%
Current year-1.93%
More quotes
1 week
118.66
Extreme 118.66
122.42
1 month
118.63
Extreme 118.625
131.61
Current year
118.63
Extreme 118.625
133.90
1 year
102.00
Extreme 102
149.25
3 years
100.39
Extreme 100.39
180.36
5 years
74.37
Extreme 74.37
180.36
10 years
74.37
Extreme 74.37
180.36
More quotes
Managers TitleAgeSince
Chief Executive Officer 48 31/10/18
Director of Finance/CFO 55 30/06/19
Chief Tech/Sci/R&D Officer - 06/06/21
Members of the board TitleAgeSince
Director/Board Member 68 31/12/06
Director/Board Member 68 31/12/08
Director/Board Member 51 11/12/14
More insiders
Date Price Change Volume
26/04/24 119.4 -0.33% 1,099,241
25/04/24 119.8 -1.17% 1,078,820
24/04/24 121.2 -0.29% 978,733
23/04/24 121.5 +0.61% 742,806
22/04/24 120.8 +1.13% 918,343

Delayed Quote Nyse, April 26, 2024 at 09:00 pm

More quotes
Zimmer Biomet Holdings, Inc. specializes in designing, manufacturing, and selling orthopedic and dental reconstruction implants, spinal implants, and traumatology products. Net sales break down by family of products as follows: - reconstruction implants (57.5%): knees replacement (58.8% of net sales), hips replacement (41.2%); - surgical products and traumatology equipment (22.1%); - dental, spinal and craniomaxillofacial implants (12.8%); - other (7.6%): primarily orthopedic surgery materials and instruments used during post-operative rehabilitation. At the end of 2021, the group had approximately 30 production sites worldwide. Net sales are distributed geographically as follows: Americas (61.3%), Europe/Middle East/Africa (21.3%) and Asia/Pacific (17.4%).
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
119.4 USD
Average target price
137.1 USD
Spread / Average Target
+14.91%
Consensus